Explore the Agenda

Pre-Conference Day

17, November 26

Day One

18, November 26

Day Two

19, November 26

7:00 am Morning Check-In: Served with coffee + light breakfast

7:55 am Chair’s Opening Remarks

Ana Rossi
Senior Director - Global Medical Immunology & Dupilumab Dermatology, Sanofi

8:00 am Keynote: Shaping The Future of Skin Therapeutics: Clinical Momentum & Strategic Innovation

Alexa Kimball
Chief Executive Officer & President, Harvard Medical Faculty Physicians
  • Evaluating progress in dermatological therapies by reviewing approved products and late-stage clinical assets in conditions like acne, atopic dermatitis, and psoriasis
  • Exploring market potential in underserved segments of dermatology, including paediatric patients, rare inflammatory diseases, and post-biologic maintenance strategies
  • Evaluating tools with the most promise for the future: from AI, synthetic biology platforms, and scalable topical manufacturing to unlock next-gen innovations

Pioneering The Next Generation Of Dermatology Innovation Through Mechanistic Precision, Digital Disruption & Deeper Disease Understanding

8:30 am SCARLETRED AI for Next-Gen Dermatology Research: Blending Human Experience with Machine Learning Precision

Harald Schnidar
Chief Executive Officer & President, SCARLETRED Holding GmbH
  • Standardized, high-resolution mobile imaging for consistent and scalable data capture across clinical sites
  • Smart Image analysis powered by objective data and machine learning in Psoriasis, Hidradenitis Suppurativa, and other inflammatory skin diseases
  • Real-time AI-driven decision support tools to enhance clinical trial design and execution
  • Development of digital biomarkers and novel endpoints to accelerate treatment validation in clinical R&D and post-marketing studies

Right click on the image to save it to your computer.

9:00 am Advancing Precision Repigmentation Through Real-World Learnings in Vitiligo

Diana Stefani-Hunyady
Sr. Medical Director, Incyte Corporation
  • Key outcomes and safety insights from adult and adolescent trials investigating topical JAK inhibition in Vitiligo
  • Translating clinical success to pediatric populations and adapting protocols for less extensive disease
  • Navigating operational and regulatory challenges including enrollment barriers and long-term data expectations
  • Applying lessons from Atopic Dermatitis programs to improve trial design, endpoint strategy, and FDA alignment in Vitiligo

9:30 am Speed Networking

10:00 am Morning Break & Refreshments

No day selected
No day selected

Track Heading

No day selected
No day selected
No day selected

Track Heading

No day selected
No day selected
No day selected
Track Name
Track Name
No day/stream selected
Track Name
Track Name
Track Name
No day selected
No day selected
No day selected
Day Two
Pre-Conference Day
View Event Brochure